Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks Funman.
I found it very confusing it as well
Details...Questions...Benefits...Aleafia Health Completes Clinic Assets Transaction with Myconic Capital Corp.
WOW, I don't know where to begin. If Canabo contributes little to revenues and profits, why does Myconic want it, and who is/was GrowWise?
As evidence that Canabo contributed little to Aleafia, the consideration of 7,000,000 common shares in the capital of Myconic, issued at an issue price of $1.50 per share, in satisfaction of a purchase price of $10.5 million seems pretty small to me.
This seems really onerous to me--->>> Canabo has agreed to continue to staff and generally operate the clinics for the benefit of Myconic for a period of ten years, --->>> who pays for the staffing, and why would Aleafia want the headaches of still managing the clinics?
And what the heck does this mean?--->>> Canabo will pay Myconic a licensing fee for the use of the Purchased Assets in connection with the Services as it will retain certain third party revenue generated from the performance of the Services. --->>>Is Aleafia paying them for the obligation to manage the stores?
This appears to be so complicated, without a clear cut benefit to Aleafia, that it seems to me as if it is designed to hide something --->>> Additionally, Canabo will receive a fee from Myconic for performing the Services. --->>> First they pay money and next they receive money? I hope Aleafia is going to explain what this transaction means and what the benefits are because it seems to me to be a whole bunch of BS. - FUNMAN
TORONTO, May 10, 2021 – Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that its wholly-owned subsidiaries, Canabo Medical Corporation (“Canabo”) and GrowWise Health Limited (“GrowWise”), (together the “Vendors”) have closed a transaction (the “Transaction”) with Myconic Capital Corp. (CSE: MEDI) (“Myconic”) whereby the Vendors sold certain of their respective clinic assets to Myconic. Additionally, Canabo has agreed to continue to staff and generally operate the clinics for the benefit of Myconic for a period of ten years, through a Clinic Services and License Agreement (the “Services Agreement”) between Canabo and Myconic, ensuring that there will be no interruption to medical services offered to existing patients.
Pursuant to an Asset Purchase Agreement, the Vendors sold to Myconic certain clinic leases, inventory, equipment and contracts, all relating to clinic operations (which excludes all patient records) (collectively the “Purchased Assets”).
As consideration for the Purchased Assets, Canabo and GrowWise were issued and delivered an aggregate of 7,000,000 common shares in the capital of Myconic, issued at an issue price of $1.50 per share, in satisfaction of a purchase price of $10.5 million, (the “Consideration Shares”) on the closing of the Transaction. The Consideration Shares are subject to a contractual lockup whereby the Consideration Shares will be released and become freely tradeable in several tranches over a period of 12 months following closing. No finder’s fees are payable as a result of the Transaction.
As previously announced due to the COVID-19 pandemic, since March 2020 the Company’s clinic network has conducted 100 per cent of cannabis patient consultations virtually and will continue to provide best-in-class cannabinoid therapy to patients under the virtual-only model through the clinics and other Purchased Assets licensed from Myconic.
Under the Services Agreement, Canabo will provide such services as are necessary to maintain the operation of the Clinics in respect of medical cannabinoid education, therapy and treatment substantially consistent with past practice (the “Services”). Canabo will pay Myconic a licensing fee for the use of the Purchased Assets in connection with the Services as it will retain certain third party revenue generated from the performance of the Services. Additionally, Canabo will receive a fee from Myconic for performing the Services.
Myconic intends to expand the services offered at the purchased clinics to include a broader scope of mental health treatments, including ketamine-assisted psychotherapy.
In addition, Aleafia Health and Myconic have entered into a nomination rights agreement, which provides Aleafia with, among other things, the right to nominate or appoint one of the five members of Myconic’s board of directors following closing (subject to customary eligibility criteria, applicable securities laws and stock exchange rules) and will be entitled to exercise this right at each of annual meetings of shareholders provided it (or its affiliates) continues to own, control or direct at least 1,000,000 common shares of Myconic.
For Investor & Media Relations:
Nicholas Bergamini, VP Investor Relations
1-833-879-2533
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com
About Aleafia Health:
Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.
Aleafia Health owns four significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.
Forward Looking Information
This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Aleafia Health Completes Clinic Assets Transaction with Myconic Capital Corp.
https://mailchi.mp/aleafiahealth.com/aleafia-health-completes-clinic-assets-transaction-with-myconic-capital-corp?e=9bbb842c5f
GLTA
You are welcome to copy and paste it wherever you like. I would love the info to get out more :) This is the only one I follow at the moment and if you are on others please feel free to share. There is a new video by bathroombeaut on youtube too. This time she talks about how CBD helps her stomach pain and she shows Aleafia products and talks about the relief she gets and how each product helps her. She shows their oil, vape and KinSlips. I really like that channel she is honest and not just doing one gram dabs. She has a lot of medical issues and she gets a great deal of help from different cannabis products. She talks about nausea, migraines, stomach pain and sleep issues to all seem be helped by cannabis. Different products for different symptoms. I have never seen anyone talk openly about how it helps them before. She is in Canada I guess because the packages are ugly.
What a helpful post! Would you consider posting that message on other ALEAF forums/message boards?
I have a family member who is a patient with Aleafia (Emblem) they have had no issues getting medication in quite a while, they used to have to place orders with other companies because somebody was always out of products, but has not had to do that for a long time. I know you can not judge by one person’s experience but it does give a good sign :) They actually do not order from any of the others because Emblem has the best prices and 2.0 formats. They were the first with vapes and the kinslips are very effective. I have a neighbour (elderly and “anti pot”) who is dealing with a recurrence of cancer. The kinslips have reduced their pain like magic. Nothing beats first hand experience.
Lets hope for goid news on the 11th
1 working day to go.
If a repeat of supply issues nothing we can do about it except buy more.
Headed to soccer practice.
Yeah buddy, she'll turn imo.
IMO, every Q this year is important confirmation of them doing the right things or not.
The 2021 Q1 report should be solid as expected.
But what if there is a repeat of supply issues that hammered revs at the end of last year. No one expected them to basically run out of supply.
Did they fix it? Will they be able to satisfy demand in Q3 when the big outdoor harvest isn't yet in.
Therefore, to no ones surprise, I'm thinking they need to continuously post rising QoQ revenues just as the big USA MSO's are doing.
It's time to get beyond talking-the-talk. They have to walk-the-walk.
So the question isn't "is this the quarter that changes things?"
The real question is, "is this the year that changes things?"
$ALEAF is this the quarter that changes things? 4 working days to go. - '$oldier Hard'
ALEAF
We all hope to see some green in the near future.
$ALEAF is this the quarter that changes things? 4 working days to go.
Aleafia Health Inc. will announce its 2021 first quarter results on May 11, 2021 prior to market open. The Company will also host its earnings conference call the same day at 8:30 a.m. EDT. The call will be hosted by CEO Geoffrey Benic and CFO Benjamin Ferdinand.
Thx FUN. Was gone all day and see not much reaction to great $ALEAF news.
Aleafia Health Secures Health Canada Research Licence for Human Sensory Analysis Trials of Cannabis Products
TORONTO, May 3, 2021 – Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, has secured a Health Canada Research Licence for its cannabis product manufacturing and innovation centre in Paris, Ont. The licence allows the Company to conduct human sensory analysis and palatability trials, evaluating the taste, touch, smell and sight of its growing portfolio of differentiated medical and consumer cannabis products.
“As we continue to bring highly innovative formats to market, our development team will now employ an important best practice of product evaluation used in the food and beverage industries,” said Aleafia Health CEO Geoffrey Benic. “Through a first to market product strategy, we’ve developed a track record for product innovation that will only be strengthened by this regulatory breakthrough.”
Aleafia Health is currently developing a number of new product formats and line extensions to complement its existing cannabis portfolio of dried flower, edibles, sublingual strips, soft gels, extracts, and vape cartridges. The Company intends to conduct sensory assessment studies consistently during product development, allowing human panels to evaluate objective product characteristics, and evaluate preference between comparable products.
For Investor & Media Relations:
Nicholas Bergamini, VP Investor Relations
1-833-879-2533
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com
About Aleafia Health:
Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and with sales and operations in Australia and Germany. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.
Aleafia Health owns four significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips, and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.
Forward Looking Information
This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
It takes a long time to be an over night success :)
Been hearing this since 2017 lol
Can’t wait u til it’s closer to $1. Take all loses and get the f$&@ out of this turd. Been waiting since 2017 and it gets worst every month.
This stock could be $5 to $10 a year from now. ALEAF!
Why? I have a drip schedule buy Monday a.m. ALEAF!
At a glance very nice for $ALEAF. I gotta run out for a couple/few hrs and will read completely when I get back.
Ty FUN.
Very nice--->>>Aleafia CORPORATE PRESENTATION APRIL 2021
https://www.aleafiahealth.com/uploads/2020/09/2021.04.15-Corporate-Presentation.pdf
Here is a cute video of a girl with a migraine trying Aleafia’s Emblem Park Life KinSlips for the first time
That has not been my experience in the weed space but it truly matters not to me. I see what this company is doing and they make products that make people feel better. I am casting a net that is global. There has never been a better time to invest on cannabis.
They never do it after hours they always deliver the shitty news in the morning
Aleafia Health to Webcast Live at VirtualInvestorConferences.com April 20th
Mon, April 19, 2021, 8:35 AM·2 min read
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com
TORONTO, April 19, 2021 /PRNewswire/ -- Aleafia Health Inc. (TSX: AH) (OTC: ALEAF), a leader in cannabis wellness products and brands, today announced that Geoffrey Benic, chief executive officer, will present live at VirtualInvestorConferences.com on April 20th.
DATE: Tuesday, April 20th
TIME: 11:00 ET
LINK: https://bit.ly/31A39N3
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.
Fourth Quarter 2020 Highlights
233% increase in Q/Q cannabis net revenue
$4.3 million positive adjusted EBITDA in Q4 2020
42% and 501% increase in Q/Q medical cannabis and adult-use net revenue, respectively
Significant product portfolio expansion with 31 new SKUs launched since October
About Aleafia Health:
Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.
Aleafia Health owns four significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.
A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group's suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
multimedia:http://www.prnewswire.com/news-releases/aleafia-health-to-webcast-live-at-virtualinvestorconferencescom-april-20th-301271202.html
SOURCE VirtualInvestorConferences.com
They are announcing before open that is a good sign. If it was bad they would announce after market on a Friday. It will still dump weed stocks always play the buy the rumour sell the news but I think they will do very well. Their new products are excellent.
Thoughts--->>>Aleafia Health to Announce 2021 First Quarter Results
Thanks for the heads-up 'Diogenes of Sinope'.
To bad mgmt hasn't said anything about the coming Q ER.
They've been mum. Is it possible they are not proud? Because we know that when they are proud, they put out PRs.
Are we waiting to see another "ER bleeder"?
Let's hope that what they indicated months ago comes true. That a lot of new shipments commenced during the 2021 Q1. - FUNMAN
Aleafia Health to Announce 2021 First Quarter Results
https://www.globenewswire.com/news-release/2021/04/16/2211581/0/en/Aleafia-Health-to-Announce-2021-First-Quarter-Results.html
This is what every q everyone is hoping. On a good PR only this stock goes down.
Greater than 5k shares holding here now :)
I do not know how the timing of all their new products will show on the next fins but their Bogart’s Kitchen gummies are now available so if not this report the next ones will....
2 new Aleafia SKUs using low all-in-cost outdoor grow. That's the reference they are making when they say "competitive advantage". --->>>
Aleafia Health Introduces Wellness Brand Noon & Night Featuring Omega CBD Soft Gels
Thanks for the find 'Diogenes of Sinope'
Read the release here to see the new product pictures.
https://aleafiahealth.com/news-releases/aleafia-health-introduces-wellness-brand-noon-night-featuring-omega-cbd-soft-gels/
Aleafia Health Introduces Wellness Brand Noon & Night Featuring Omega CBD Soft Gels
https://www.google.ca/amp/s/finance.yahoo.com/amphtml/news/aleafia-health-introduces-wellness-brand-113000322.html
Aphria struggled in their latest Q. Will Aleafia have the same story? Aphria complained about the lockdown in Ontario, but Aleafia has their delivery service so it could be possible Aleafia took market share away from Aphria! Did Aleafia launch recreational products that will be included in revenue for the next reportable Q?
God man, great post, you're a genius
$aleaf $0.51 ^ 0.0241 (4.96%)
Volume: 183,668 @04/09/21 3:58:06 PM EDT
1 Small Canadian Cannabis Stock Analysts Seem to Like Right Now
Chris MacDonald
April 11, 2021
Recently, cannabis stocks have seen massive growth amid burgeoning investor demand. Legalization efforts in the U.S. seem likely to play out in the near-term. Accordingly, there remains a tonne of investors interest in this space.
This investor interest has not escaped Canadian cannabis companies. Smaller-cap Canadian cannabis players have seen some pretty wild moves of late. Indeed, stocks like Aleafia Health Inc.(TSX:AH) have been big movers of late.
On a year-to-date basis, Aleafia stock is up 30%. That’s not bad. However, the stock is also down more than 50% from its February peak. This is a highly volatile play, and is made more volatile by its smaller market cap.
That said, analysts have recently been more bullish on this stock. Here’s why.
Bullish analyst sentiment on Aleafia
Recently, Raymond James analyst Rahul Sarugaser provided an “outperform” recommendation for Aleafia. This vote of confidence was given for multiple reasons.
First, Aleafia’s business model is one that is viewed as beneficial for long-term growth. Specifically, the company’s relatively low-cost production, top-rated cultivation and manufacturing facilities, and an array of innovative pot-based products are among the key drivers. These are key facets of any long-term investment, so this appears to be very bullish for fundamentals-oriented investors.
Additionally, Aleafia recently secured an exclusive deal with large private-sector union Unifor. This deal will support medical pot coverage for nearly 315,000 family members. Thus, expectations are that this deal could provide significant revenue growth in the second half of 2021.
Furthermore, Aleafia has been broadening its product offering. The company is set to launch a host of new SKUs aimed at the recreational cannabis market. This would supplement the company’s already diverse product portfolio.
Accordingly, the expectation is that continued growth in sales of the company’s new products, combined with its high-margin derivative products, could provide for continued strong revenue growth. The company’s net revenue growth rate of 233$ in Q4 2020 speaks to the amount of growth this company has already provided. Any sort of acceleration on this front could be very bullish for this stock.
Conclusion
The cannabis sector continues to be a highly-volatile growth market today. Accordingly, investors with lower risk tolerance levels need to consider this fact before jumping in.
Indeed, Aleafia’s stock price swings this year are an indication of how much sentiment can shift these stocks’ values in short order. While it appears the company has one analyst in its corner, the market will ultimately decide the fate of this company.
Being on the right side of the trade for such speculative plays isn’t easy. Therefore, I’m on the sidelines with respect to Aleafia right now.
14 stores open with 7 more to open soon.
One Plant up to 14 open stores. I hope Aleafia is selling through a lot of their product to them.
https://www.oneplant.ca/stores/
Aleafia's 10% stake is hopefully paying off in more ways than one.
That's good news FUN. Would be nice to see the market respond positively.
Aleafia Health Launches Everyday Cannabis Brand Divvy
I presume if they are touting their price advantages, Divvy comes from the outdoor cultivation. That should allow for a very low price point. Maybe even competitive with the black market.
They don't give that detail. - FUNMAN
https://aleafiahealth.com/news-releases/aleafia-health-launches-everyday-cannabis-brand-divvy/
Yeah, really disappointed.
What's going on over here? I keep adding but price keeps falling? ALEAF!
Probably not. It is Canadian and it does not have any operations in the USA. It is however very well positioned in the Canadian market and beyond which allows it freedom globally the US companies can not access. You have to know what you own
So now that they're making it legal in New York City will this company ever get off its feet and move
This new revelation that Biden is anti legalization will help Aleafia. They are not burdened by the grow house baggage the early LPs have yet they have international exposure the US can not. 2nd mover advantage is Aleafia’s best asset
https://www.marijuanamoment.net/bidens-opposition-to-marijuana-legalization-has-not-changed-press-secretary-says/
Followers
|
85
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3371
|
Created
|
12/08/16
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |